HUMACYTE INC shareholders Q3 2023

HUMACYTE INC's ticker is and the CUSIP is 44486Q103. A total of 84 filers reported holding HUMACYTE INC in Q3 2023. The put-call ratio across all filers is 63.87 and the average weighting 0.0%.

HUMACYTE INC shareholders Q3 2023
NameSharesValueWeighting ↓
Private Advisor Group, LLC 94,980$278,2910.00%
PRIVATE MANAGEMENT GROUP INC 15,500$45,4150.00%
Renaissance Technologies 107,500$3150.00%
TWO SIGMA INVESTMENTS, LP 117,602$344,5740.00%
MetLife Investment Management, LLC 34,928$102,3390.00%
Ameritas Investment Partners, Inc. 4,704$13,7830.00%
Verition Fund Management LLC 39,356$115,3130.00%
MARSHALL WACE, LLP 176,207$516,2870.00%
METROPOLITAN LIFE INSURANCE CO/NY 3,572$10,4660.00%
Addison Advisors LLC 1,000$2,9300.00%
AMERICAN INTERNATIONAL GROUP, INC. 30,562$89,5470.00%
LPL Financial LLC 341,482$1,000,5420.00%
FNY Investment Advisers, LLC 400$10.00%
RHUMBLINE ADVISERS 54,945$160,9790.00%
ALLIANCEBERNSTEIN L.P. 45,330$132,8170.00%
BARCLAYS PLC 23,788$700.00%
UBS Group AG 33,416$97,9090.00%
CALIFORNIA STATE TEACHERS RETIREMENT SYSTEM 13,513$39,5930.00%
VOYA INVESTMENT MANAGEMENT LLC 26,282$77,0060.00%
Avior Wealth Management, LLC 1,000$2,9300.00%

This page lists HUMACYTE INC's shareholders in Q3 2023. To view HUMACYTE INC's shareholder history, click here.